Posted on

One in five people over the age of 75 have age-related macular degeneration (ARMD). According to research led by the University College London, scientists believe there could be a breakthrough successfully treating patients with eye drops instead of unpleasant and expensive eye injections. It was previously thought that drugs used to treat ARMD such as Avastin and Lucentis have molecules that are simply too big to be efficiently transported in an eye drop. It has been shown in experimental models a formulation system to get substances including Avastin across the barriers in the eye and convey them across the barriers in the eye and transport them across the cells of the cornea. In theory, you can change the technology for different drugs such as Lucentis, as it is a smaller molecule than Avastin so likely it can be delivered successfully via eye drops. The technology has been patented by UCL’s technology company and the researchers are seeking commercial partners to accelerate development. Visit one of our 8 locations including Eye Health of Fort Myers, Eye Health of Cape Coral and Eye Health of Naples.

Blog Search

Vision Treatments & Technology

This journal will include information in the optometry and ophthamology fields including studies and other valuable eye care stories.

Links & Stuff